NCT06018571View on ClinicalTrials.gov

Burden of Illness and Treatment Assessment of Patients With Dry Eye Disease: A Cross-Sectional Survey of Real-World Patients With Dry Eye Disease in the US

CompletedOBSERVATIONAL
Enrollment

946

Participants

Timeline

Start Date

June 2, 2022

Primary Completion Date

August 19, 2022

Study Completion Date

August 19, 2022

Conditions
Dry Eye Disease
Trial Locations (1)

07936

Novartis, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY

NCT06018571 - Burden of Illness and Treatment Assessment of Patients With Dry Eye Disease: A Cross-Sectional Survey of Real-World Patients With Dry Eye Disease in the US | Biotech Hunter | Biotech Hunter